Angst and the amygdala

Dialogues in Clinical Neuroscience

Volumn 8, Issue 4, 2006, Pages 407-416

  Schulkin, Jay ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

Author keywords

Amygdala; Angst; Fear

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; HYDROCORTISONE; NEUROPEPTIDE;

AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; ATTENTION; BRAIN FUNCTION; DEPRESSION; FEAR; HUMAN; NONHUMAN; PROTEIN EXPRESSION;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; FEAR; GLUCOCORTICOIDS; HUMANS;

EID: 33846226946     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (162)

1. Darwin C. The Expression of the Emotions in Man and Animals. Chicago; Ill: University of Chicago Press; 1972/1965.
2. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry. 2001;6:13-34.
3. Rosen JB, Schulkin J. From normal fear to pathological anxiety. Psychol Rev. 1998;105:325-350.
4. Mineka S, Watson D, Clark LA. Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psychol. 1998; 49:377-412.
5. LeDoux JE. The Emotional Brain. New York, NY: Simon and Schuster. 1996
6. Charney DS. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand. 2003;417:38-50.
7. Kagan J, Schulkin J. On the concepts of fear. Harv Rev Psychiatry. 1995;3:231-234.
8. Schulkin J. Sodium Hunger. Cambridge, UK: Cambridge University Press; 1991.
9. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H. Aversive and appetitive events evoke the release of CRH and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci. 1998;18:4758-4766.
10. Easter J, McClure EB, Monk CS, et al. Emotion recognition deficits in pediatric anxiety disorders: implications for amygdala research. J Child Adol Psychopharmacol. 2005;15:563-570.
11. Schwartz, CE, Wright CL, Shin LM, Kagan J, Rauch SL. Inhibited and uninhibited infants' grown up adult amygala responses to novelty. Science. 2003;300:1952-1953.
12. Amaral DG, Price JL, Pitkanen A, Carmichael ST. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP, ed. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York, NY: Wiley; 1992:1-66.
13. Krettek JE, Price JL. Amygdaloid projections to subcortical structures within the basal forebrain and brain stem in the rat and cat. J Comp Neurol. 1978;78:225-254.
14. Petrovich GD, Canteras NS, Swanson, LW. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Rev. 2001;38:247-289.
15. Stefanacci L, Amaral DG. Some observations on cortical inputs to the macaque monkey amygdala: an anterograde tracing study. J Comp Neurol. 2002;451:301-323.
16. Pitkanen A, Savander V, LeDoux JE. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 1997;20:517-523.
17. LeDoux JE. Emotion circuits in the brain. Ann Rev Neurosci. 2000;23:155-184.
18. Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 1978;153:1-26.
19. Schwaber JS, Kapp BS, Higgins G. A, Rapp PR. Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus. J Neurosci. 1982;2:1424-1438.
20. Nauta WJ, Domesick VB. Afferent and efferent relationships of the basal ganglia. CIBA Found Symp. 1984;107:3-29.
21. Yim CY, Mogenson GJ. Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine. Brain Res. 1982;239:401-415.
22. Swanson LW. Cerebral hemisphere regulation of motivated behavior (1). Brain Res. 2000;886:113-164.
23. Amorapanth P, LeDoux JE, Nader K. Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus. Nat Neurosci. 2000;3:74-79.
24. Gray TS. Functional and anatomical relationships among the amygdala, basal forebrain,ventral striatum, and cortex. An integrative discussion. Ann N Y Acad Science. 1999;877:439-444.
25. Swanson LW, Petrovich GD. What is the amygdala? Trends Neurosci. 1998;21:323-331.
26. Pitkanen A. Connectivity of the rat amygdaloid complex. In: Aggleton JP, ed. The Amygdala: a Functional Analysis. 2nd ed. New York, NY: Oxford University Press; 2000:31-116.
27. Davidson RJ. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry. 2002;51:68-80.
28. Sotres-Bayon F, Bush DE, LeDoux J. Emotional perseveration. Learn Mem. 2004;11:525-534.
29. Ledoux JE, Iwata J, Cicchetti P, Reis DJ. J Neurosci. 1988; 8:2517-2529.
30. Rosen JB, Davis M. Enhancement of electrically elicited startle by amygdaloid stimulation. Physiol Behav. 1990;48:343-349.
31. Rosen JB, Hitchcock JM, Sananes CB, Miserendino MJ. D, Davis M. A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav Neurosci. 1991;105:817-825.
32. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci U S A. 2002;99:13908-13913.
33. Roozendaal B, Qkuda S, Van der Zee EA, McGaugh JL. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A. 2006;103:6741-6746.
34. Dong HW, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Rev. 2001;38:192-246.
35. Norgren R. Gustatory system. In: Paxinos G, ed. The Rat Nervous System. New York, NY: Academic Press; 1995.
36. Murray EA, Wise SP. What, if anything, is the temporal lobe, and how can the amygdala be part of it if there is no such thing? Neurobiol Learn Mem. 2004;82:178-198.
37. Angrilli A Mauri A, Palomba D, et al. Startle reflex and emotion modulation impairment after a right amygdala lesion. Brain. 1996;119:1991-2000.
38. LaBar KS, LeDoux JE, Spencer DD, Phelps EA. Impaired fear conditioning following unilateral temporal lobectomy in humans. J Neurosci. 1995;15:6846-6855.
39. Adolphs R Tranel D, Damasio H, Damasio AR. Fear and the human amygdala. J Neurosci. 1995;15:5879-5891.
40. Allman J, Brothers L. Neuropsychology. Faces, fear and the amygdala. Nature. 1994;372:613-614.
41. Funayama ES, Grillon C, Davis M, Phelps EA. A double dissociation in the affective modulation of startle in humans: effects of unilateral temporal lobectomy. J Cogn Neurosci. 2001;13:721-729.
42. Ketter TA, Andreason PJ, George MS, et al. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry. 1996;53:59-69.
43. Morris JS, Frith CD, Perrett DI, et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature. 1996;383:812-815.
44. Whalen PJ, Shin LM, Somerville LH, McLean AA, Kim H. Functional neuroimaging studies of the amygdala in depression. Sem Clin Neuropsychiatry. 2002;7:234-242.
45. Breiter HC, Etcoff NL, Whalen PJ, et al. Response and habituation of the human amygdala during visual processing of facial expression. Neuron. 1996;17:875-887.
46. Erickson K, Mah L, Schulkin J, et al. Influence of low and high hydocorticosterone infusion on demondynamic response in the amygdala. Neuroscience Abstracts. 2005.
47. Lane RD, Nadel L. Cognitive Neuroscience of Emotion. New York, NY: Oxford University Press; 2000.
48. Wright CI, Fischer H, Whalen PJ, et al. Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport. 2001;12:379-383.
49. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36:165-186.
50. Gray TS. The organization and possible function of amygdaloid corticotropin-releasing hormone pathways. In: De Souza EB. Nemeroff CB, eds. Corticotropin-Releasing Hormone: Basic and Clinical Studies of a Neuropeptide. Boca Raton, Fl: CRC; 1990.
51. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981 213:1394-1397.
52. Koob GF, Heinrichs SC, Pich EM, et al. The role of corticotropin- releasing factor in behavioural responses to stress. Ciba Found Symp. 1993;172:277-289.
53. Kalin NH, Takahashi LK. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems. Brain Res. 1990;509:80-84.
54. Makino S, Gold PW, Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis: Comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res. 1994;657:141-149.
55. Valentino RJ, Foote SL, Page ME. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Science. 1993;697:173-188.
56. Valentino RJ, Page ME, Luppi PH, Zhu Y, Van Bockstaele E, Aston-Jones G. Evidence for widespread afferents to Barrington's nucleus, a brainstem region rich in corticotropin-releasing hormone neurons. Neuroscience, 1994;62:125-143.
57. Dautzenberg FM, Higelin J, Brauns O, Butscha B, Hauger RL. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart. Mol Pharmacol. 2002;61:1132-1139.
58. Lovenberg TW, Liaw C. W, Grigoriadis DE, et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Science U S A. 1995;92:836-840.
59. Aguilera G, Nikodemoca M, Wynn PC, Catt KJ. Corticotropin releasing hormone receptors: two decades later. Peptides. 2004;25:319-329.
60. Van Pett K, Vlau V, Bittencourt JC, et al. Distribution of mRNAs encoding CRF receptor in brain and pituitary of rat and mouse. J Comp Neurol. 2000; 428:191-212.
61. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Science. 1999;885:312-328.
62. Potter E, Sutton S, Donaldson C, et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Science U S A. 1994;91:8777-8781.
63. Lim MM, Nair HP, Young LJ. Species and sex differences in brain distribution of CRF receptor subtypes 1 and 2 in monogamous and promiscuous vole species. J Comp Neurol. 2005;487:75-92.
64. Primus RJ, Yevich E, Baltazar C, Gallager DW. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology. 1997;17:308-316.
65. Dallman MF, Akana SF, Jacobson L, Levin N, Cascio CS, Shinsako J. Characterization of corticosterone feedback regulation of ACTH secretion. Ann N Y Acad Science. 1987;512:402-414.
66. Swanson LW, Simmons DM. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the PVN. J Comp Neurol. 1989;285:413-435.
67. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21:55-89.
68. Joels M, Hesen W, Karst H, de Kloet ER. Steroids and electrical activity in the brain. J Steroids Biochem Mol Biol. 1994;49:391-398.
69. Orchinik M, Carroll SS, Li YH, McEwen BS, Weiland NG. Heterogeneity of hippocampal GABA (A) receptors: regulation by corticosterone. J Neurosci. 2001;21:330-339.
70. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997;20:78-84.
71. Herman JP, Tasker JG, Ziegler DR, Cullinan WE. Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections. Pharmacol Biochem Behav. 2002;71:457-468.
72. Tanimura SM, Watts AG. Corticosterone can facilitate as well as inhibit corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus. Endocrinology. 1998;139:3830-3836.
73. Palkovits M, Young WS, Kovacs K, Toth Z, Makara, GB. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Neuroscience. 1998;85:135-147.
74. Watts AG. The impact of physiological stimuli on the expression of corticotropin-releasing hormone (CRH) and other neuropeptide genes. Neuroendocrinology. 1996;17:281-326.
75. Watts AG, Sanchez-Watts G. Region-specific regulation of the neuropeptide mRNAs in rat limbic forebrain neurons by aldosterone and corticosterone. J Physiol. 1995;484:721-736.
76. Thompson BL, Erickson K, Schulkin J, Rosen JB. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res. 2004;149:209-215.
77. Plotky PM, Thrivikraman KV, Nemeroff CB, Caldji C, Sharma S, Meaney MJ. Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology. 2005;30:2192-2204.
78. Coplan JD, Smith EL, Altemus M, et al. Variable foraging demand rearing: sustained elevations in cerebrospinal fluid CRH concentrations in adult primates. Biol Psychiatry. 2001;50:200-204.
79. Hammack SE, Pepin JL, DesMarteu JS, Watkins LR, Maier SF. Low doses of corticotropin-releasing hormone injected into the dorsal raphe rat nucleus block the behavioral consequences of uncontrollable stress. Behav Brain Res. 2006;147:55-64.
80. Takahashi LK, Kalin NH, Vanden Burgt JA, Sherman JE. Corticotropin- releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci. 1989;103:648-654.
81. Swiergiel AH, Takahashi LK, Rubin WW, Kalin NH. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res. 1992;587:263-268.
82. Johnson LR, Farb C, Morrison JH. McEwen, BS LeDoux, JE. Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience. 2005;136:289-299.
83. Schulkin J, Morgan MA, Rosen JB. A neuroendocrine mechanism for sustaining fear. Trends Neurosci. 2005;28:629-635.
84. Takahashi LK. The organizing action of corticosterone on the development of behavioral inhibition. Developmental Brain Res. 1994,81:121-127.
85. Schulkin J, McEwen BS, Gold PW. Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev. 1994;18:385-396.
86. Dallman MF, Bhatnager S. Chronic Stress: Role of the Hypothalamo-pituitary-adrenal Axis. Handbook of Physiology. New York, NY: Oxford University Press; 2000.
87. Pecina S, Schulkin J. Berridge, KC. Nucleus accumbens CRF increases cue-triggered motivation for sucrose reward. BMC Biology. 2006;4:1-16.
88. Brier A. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol Psychiatry. 1989;26:438-462.
89. Mason JW. A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosomat Med. 1968;30(suppl):576-607.
90. Habib KE, Weld KP, Rice KC, et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A. 2000;97:6079-6084.
91. Richter CP. Domestication of the Norway rat and its implications for the problem of stress. Res Publ Assoc Res Nerv Ment Dis. 1949;29:19-30.
92. Roozendaal B. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology. 2000;25:213-238.
93. Donley MP, Schulkin J, Rosen JB. Glucocorticoid receptor antagonism in the basolateral amygdala and ventral hippocampus interferes with long-term memory of contextual fear. Behav Brain Res. 2005;164:197-205.
94. Cordero MI, Merino JJ, Sandi C. Correlational relationship between shock intensity and coricosterone secretion on the establishment and subsequent expression of contextual fear conditioning. Behav Neurosci. 1998;112:885-891.
95. Pugh CR, Fleshner M, Rudy JW. Type II glucocorticoid receptor antagonists impair contextual but not auditory-cue fear conditioning in juvenile rats. Neurobiol Learn Mem. 1997;67:75-79.
96. Corodimas KP, LeDoux JE, Gold PW, Schulkin J. Corticosterone potentiation of conditioned fear in rats. Ann N Y Acad Sci. 1994;746:392-393.
97. Yang Y. L, Chao PK, Lu KT. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology. 2006;31:912-924.
98. Shepard JD, Barron KW, Myers DA. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res. 2000;861:288-295.
99. Shepard JD, Schulkin J, Myers DA. Corticosterone delivery to the amygala increases coricotropin releasing factor mRNA in the dorsal lateral region of the bed nucleus of the stria termimalis. Neuroscience Abstracts. 2005.
100. Myers DA, Gibson M, Schulkin J, Van-Meerveld B. Corticosterone implants to the amygdala and TYPE 1 CRH receptor regulation. Behav Brain Res. 2005;161:39-44.
101. Arborelius L Skelton KH, Thrivikraman K, et al. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. J Pharmacol Exp Ther. 2000;294:588-597.
102. Aubry JM, Turnbull A, Pozzoli VG, Rivier C, Vale W. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Endocrinology. 1997;138:1621-1626.
103. Smith GW, Aubry JM, Dellu F, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20, 1093-1102.
104. Bale TL, Vale WW. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J Neurosci. 2003;23:5295-5301.
105. Takahashi LK. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci Biobehav Rev. 2001;25:627-636.
106. Cook CJ. Glucocorticoid feedback increases the sensitivity of the limbic system to stress. Physiol Behav. 2002;75:455-464.
107. Davis M, Walker D. L, Lee Y. Amygdala and bed nucleus of the stria terminalis: Differential roles in fear and anxiety measured with the acoustic startle reflex. In: Squire L, Schacter D, eds. Biological and Psychological Perspectives on Memory and Memory Disorders. Washington, DC: American Psychiatric Association Press; 1997.
108. Hitchcock JM, Davis M. Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci. 1991;105, 826-842.
109. Walker DL, Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci. 1997;17:9375-9383.
110. Lee Y, Schulkin J, Davis M. Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF). Brain Res. 1994;666:93-99.
111. Fendt M, Endres T, Apfelbach R. Temporary inactivation of the bed nucleus of the stria terminalis but not of the amygdala blocks freezing induced by trimethylthiazoline, a component of fox feces. J Neurosci. 2003;23:23-28.
112. Wallace KJ, Rosen JB. Neurotoxic lesions of the lateral nucleus of the amygdala decrease conditioned fear, but not unconditioned fear of a predator odor: comparison to electrolytic lesions. J Neurosci. 2001;21:3619-3627.
113. Kalynchuk LE. Corticosterone increased depression-like behavior, with some effects on predator oder-induced defensive behavior in male and female rats. Behav Neurosci. 2004;118:1365-1377.
114. Erb S, Salmaso N, Rodaros D, Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology. 2001;158:360-365.
115. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
116. Grillon C, Baas JM, Pine DS, et al. The benzodiazepine Alprazolan dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry. 2006;60:760-766.
117. Kagan J, Resnick JS, Snidman N. Biological basis of childhood shyness. Science. 1988;240:167-171.
118. Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav. 2002;71:431-447.
119. Abercrombie HC, Schaefer SM, Larson CL, et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport. 1998;9:3301-3307.
120. Carroll BJ. Urinal free cortisol excretion in depression. Psychol Med. 1976;6:43-50.
121. Nemeroff CB, Krishnan KR, Reed D, et al. Adrenal gland enlargement in major depression. Arch Gen Psychiatry. 1992;49:384-387.
122. Gold PW, Drevets WC, Charney DS. New insights ito the role and the glucocorticoid receptor in severe depression. Biol Psychiatry. 2002;52:381-385.
123. Reus VI, Wolfkowitz OM. Antigluocorticoid drugs in the treatment of depression. Expert Opin Investig Drugs. 2001;10:1709-1796.
124. Flores BH, Kenna H, Keller J, Solvason HM, Schatzberg AF. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology. 2006;31:628-636.
125. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol. 1999;160:1-12.
126. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477-501.
127. Nemeroff CB. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivty in depressed patients. Science. 1984;26:1342-1343.
128. Wong ML, Kling MA, Munson PJ, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A. 2000;97:325-330.
129. Carpenter LL, Tyrka AR, McDougle CS, et al. Cerebrospinal fluid CRF and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology. 2004;29:777-784.
130. Zobel AW, Nickel T, Kunzel HE, et al. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psych Res. 2000;34:171-181.
131. Fu CH, Williams SC, Cleare AJ, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment. Arch Gen Psychiatry. 2004;61:877-889.
132. Surguladze S, Brammer MJ Keedwell P, et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry. 2005;57:201-209.
133. Frodl T, Meisenzahl E, Zetzsche T, et al. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry. 2002;51:708-714.
134. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann NY Acad Sci. 2003;985:420-444.
135. Schmidt LA, Fox NA, Rubin KH, et al. Behavioral and neuroendocrine responses in shy children. Devel Psychobiol. 1997;30:127-140.
136. Vyas A, Mitra R, Shankaranarayana Rao B S, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 2002;22:6810-6818.
137. Wellman CL. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol. 2001;49:245-253.
138. Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990;531:225-231.
139. Mitra R, Jadhav S, McEwen BS, Vyas A, Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc Natl Acad Sci U S A. 2005;102:9371-9376.
140. Matys T, Pawlak R, Matys E, Pavilides C, McEwen BS, Strickland S. Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc Nat Acad Sci U S A. 2004;101:16345-16350.
141. Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry. 2002;51:693-707.
142. Dallman MF, Pecoraro N, Akana SF, et al. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci U S A. 2003;100:11696-701.
143. Soravia LM, Heinrichs M Aerni A, et al. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A. 2006;103:5585-5590.
144. Mason JW, Giller EL, Kosten TR, Harkness L. Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder. J Nerv Ment Dis. 1988;176, 498-502.
145. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psych Clin N Am. 2002;25:341-368.
146. Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry. 1991;30:1031-1048.
147. Baker DG, Ekhator NN, Kasckow JW, et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in post-traumatic stress disorder. Neuroimmunomodulation. 2001;9:209-217.
148. Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 1997;154:624-629.
149. Birbaumer N, Grodd W, Diedrich O, et al. fMRI reveals amygdala activation to human faces in social phobics. Neuroreport. 1998;9:1223-1226.
150. Rauch SL, van der Kolk BA, Fisler RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry. 1996;53:380-387.
151. Rauch SL, Whalen PJ, Shin LM, et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry. 2000;47:769-776.
152. Stein MB, Goldin PR, Sareen J, et al. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry. 2002;59:1027-1034.
153. Schneider F, Weiss U, Kessler C, et al. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry. 1999;45:863-871.
154. Quirk GJ, Russo GK, Barron JL, Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci. 2000;20:6225-6231.
155. Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: role of the amygdala and vmPFC. Neuron. 2004;43:897-405.
156. Morgan MA, LeDoux JE. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci. 1995;109:681-688.
157. Spencer S.J, Buller KM Day TA. Medial prefrontal cortex control of the PVN to psychological stress: possible role of the bed nucleus of the stria terminalis. J Comp Neurol. 2005;481:363-376.
158. Sullivan RM, Gratton A. Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology. 2002;27:99-114.
159. Dioro D, Viau V, Meaney MJ. The role of the medial prefrontal cortex in the regulation of the HPA axis to sress. J Neurosci. 1993;13:3839-3847.
160. Kluver H, Bucy PC. Preliminary analysis of functions of the temporal lobes in monkeys. Arch Neurol Psychiatry. 1939;42:979-1000.
161. Michelson D, Altemus M, Galliven E, Hill L, Greenberg BD, Gold P. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive-compulsive disorder, and healthy controls. Neuropsychopharmacology. 1996;15:207-212.
162. Nemeroff CB. New vistas in neuropeptide research in neuropsychiatry: focus on CRF. Neuropsychopharmacology. 1992;6:69-75.